Taniguchi, T.; Iinuma, K.; Kawada, K.; Ishida, T.; Takagi, K.; Tomioka, M.; Kawase, M.; Kawase, K.; Nakane, K.; Tobisawa, Y.;
et al. Real-World Oncological Outcomes of Nivolumab Plus Ipilimumab in Advanced or Metastatic Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study in Japan. Curr. Oncol. 2024, 31, 7914-7923.
https://doi.org/10.3390/curroncol31120583
AMA Style
Taniguchi T, Iinuma K, Kawada K, Ishida T, Takagi K, Tomioka M, Kawase M, Kawase K, Nakane K, Tobisawa Y,
et al. Real-World Oncological Outcomes of Nivolumab Plus Ipilimumab in Advanced or Metastatic Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study in Japan. Current Oncology. 2024; 31(12):7914-7923.
https://doi.org/10.3390/curroncol31120583
Chicago/Turabian Style
Taniguchi, Tomoki, Koji Iinuma, Kei Kawada, Takashi Ishida, Kimiaki Takagi, Masayuki Tomioka, Makoto Kawase, Kota Kawase, Keita Nakane, Yuki Tobisawa,
and et al. 2024. "Real-World Oncological Outcomes of Nivolumab Plus Ipilimumab in Advanced or Metastatic Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study in Japan" Current Oncology 31, no. 12: 7914-7923.
https://doi.org/10.3390/curroncol31120583
APA Style
Taniguchi, T., Iinuma, K., Kawada, K., Ishida, T., Takagi, K., Tomioka, M., Kawase, M., Kawase, K., Nakane, K., Tobisawa, Y., & Koie, T.
(2024). Real-World Oncological Outcomes of Nivolumab Plus Ipilimumab in Advanced or Metastatic Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study in Japan. Current Oncology, 31(12), 7914-7923.
https://doi.org/10.3390/curroncol31120583
